Results 141 to 150 of about 1,293,738 (268)

Early health technology assessment: current and future perspectives from a health technology assessment agency. [PDF]

Int J Technol Assess Health Care
Jarrom D.
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Methodological guidelines for Health Technology Assessment in Oman. [PDF]

J Pharm Policy Pract
Wani S, Alsabti H, Allamki S, Almandhari A, Alhajji S, Alrashdi I, Al Sabri R, Alqassabi A, Alzaabi A, Almaashani A, Ashuaili A, Rasool A, Alkindi A, Salman B, Alzadjali F, Al Rahbi K, Almutawa K, Alansari M, AlKharusi M, AlBulushi N, Alghadani R, Aljaber R, Almuaini S, Alkindi S, Alzawamri S, Albalushi S, Al Lawati S, Alsalti Z, AlBalushi H, Fasseeh AN, Kaló Z.   +30 more
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Unlocking the Potential of Health Technology Assessment (HTA) in Indonesian Midwifery: Challenges and Opportunities. [PDF]

Health Sci Rep
Adnani QES, Pratiwi IG, Susanti AI, Giri B.   +3 more
europepmc   +1 more source

Raman‐based label‐free microscopic analysis of the pancreas in living zebrafish larvae

FEBS Open Bio, EarlyView.
Forward stimulated Raman scattering (F‐SRS) and epi coherent anti‐Stokes Raman scattering (E‐CARS) allow label‐free discrimination of distinct subcellular structures in the pancreas of living zebrafish larvae. Given the straightforward applicability, we anticipate broad implementation of Raman microscopy in other organs and across various biomedical ...
Noura Faraj, Eline M. F. de Lange, Klaas A. Sjollema, Ben N. G. Giepmans   +3 more
wiley   +1 more source

The evolution of cancer therapies and their Implications for health technology assessment in Australia. [PDF]

Cost Eff Resour Alloc
Jones AM, Goodall S, Liew D, Kim H.
europepmc   +1 more source

Suppression of lung adenocarcinoma migration through organelle alkalization by human lactoferrin – albumin fusion

FEBS Open Bio, EarlyView.
This paper reveals how human lactoferrin–albumin fusion (hLF‐HSA) potently suppresses lung adenocarcinoma cell migration. hLF‐HSA upregulates NHE7, leading to Golgi alkalization, disruption of the Golgi secretome, downregulation of MMP1, and reversal of EMT. These findings suggest a novel Golgi‐targeting strategy to suppress cancer cell migration.
Hana Nopia, Masahiro Kimura, Daisuke Kurimoto, Atsushi Sato   +3 more
wiley   +1 more source

Strengthening health technology assessment in Greece: industry-identified barriers and recommendations. [PDF]

Front Public Health
George P, Eleftheria K, Kostas A.
europepmc   +1 more source

For Full Technological Assessment [PDF]

Science, 1969
openaire   +2 more sources